article thumbnail

Nioko Resources Files Early Warning Report in Respect of Orezone Gold Corporation

Benzinga

Pursuant to a binding subscription agreement dated July 9, 2024 (the " Subscription Agreement "), the Acquiror has acquired deemed beneficial ownership (in accordance with section 1.8 per Acquired Share for aggregate consideration of C$64,920,698.50 (the " Equity Financing "). Vancouver, British Columbia, V7X 1M3.

article thumbnail

Orthobiologics Market is Poised to Register CAGR of 5.5% by 2031 | SkyQuest Technology

Benzinga

22, 2024 (GLOBE NEWSWIRE) -- Orthobiologics Market size was valued at USD 6.43 during the forecast period (2024-2031). during the forecast period (2024-2031). The firm closed a round of equity financing for USD 12.7 Forecast Period 2024–2031 Full story available on Benzinga.com Westford, USA, Oct.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Goodwin Procter Discusses Add-On Acquisitions in Private Equity

Reynolds Holding

By the end of 2022, add-on acquisitions represented more than 76% of all private-equity-backed buyouts, which was a significant increase compared to a decade earlier. The percentage of add-ons dipped by 1% in 2023 — a year when volume and value of buyouts dropped significantly — and reached 76% in the first three months of 2024.

Equity 45
article thumbnail

WSP to Acquire Power Engineers Setting a Milestone for Accelerated Growth

Benzinga

12, 2024 (GLOBE NEWSWIRE) -- WSP (TSX: WSP ) ("WSP", the "Corporation", "we", "us" or "our"), a leading global professional services firm, proudly announces it has entered into an agreement to acquire Power Engineers, Incorporated ("POWER") a prominent U.S. The Acquisition is expected to be completed in the early fourth quarter of 2024.

article thumbnail

Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Benzinga

13, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. Markovic, M.D., NASDAQ: ENTO ) ("Entero" or the "Company"), today announced that it has entered into a binding term sheet for a reverse merger transaction (the "Proposed Merger") with Journey Therapeutics, Inc. Chairman and Chief Executive Officer of Journey Therapeutics.

article thumbnail

Tactical Resources Provides Additional Information Regarding Its Proposed Business Combination With Plum Acquisition Corp. III

Benzinga

28, 2024 (GLOBE NEWSWIRE) -- Tactical Resources Corp. Proposed Business Combination As previously announced, Tactical Resources entered into a definitive business combination agreement (the "Business Combination Agreement") with Plum on August 22, 2024. VANCOUVER, British Columbia, Aug. million, calculated on a fully diluted basis.

article thumbnail

G Mining Ventures and Reunion Gold Announce Combination to Set the Stage for a Leading Intermediate Gold Producer in the Americas

Benzinga

per RGD common share, an estimated Transaction equity value of $875 million, based on the closing price of GMIN common shares on the Toronto Stock Exchange (" TSX ") on April 19, 2024, excluding the value of the SpinCo consideration. RGD shareholders will receive estimated consideration of $0.65